Across TCGA pan-cancer cohorts, GLRX3P2 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of GLRX3P2’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where GLRX3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GLRX3P2 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.
COAD, LUAD, and LUSC are the cancer types where GLRX3P2 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GLRX3P2 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.